$VTRS news
The latest VTRS stock news: headlines, filings, AI summaries and sentiment for $VTRS, updated around the clock.
- Ingram Micro to Join S&P SmallCap 600 Replacing Pacira BioSciences
- Ingram Micro to Join S&P SmallCap 600 Following Pacira BioSciences Acquisition by Viatris
- Ingram Micro Holding Corp. to Join S&P SmallCap 600 Replacing Pacira BioSciences
- Opus Genetics Reports Q3 Earnings Miss on Lower Revenue and Negative EPS
- Healthcare Sector Reports Strong Earnings Performance with 96% EPS Beat Rate
- Viatris Reports Q3 2026 Results with Raised Full-Year Guidance Amid Supply Constraints
- Lexicon Pharmaceuticals Reports Q3 2026 Financial Results and Clinical Pipeline Updates
- Viatris Reports Q3 2026 Results with $3.75 Billion Revenue and Future Growth Targets
- Viatris Inc - 10-Q Filing
- Viatris Inc - 8-K Filing
- Viatris Reports Stable $3.75B Revenue Driven by Growth in Greater China
- Key Corporate Earnings Reports Scheduled Before Market Open on Thursday
- Coca-Cola Consolidated Reports Q3 2026 Financial Results
- Viatris Announces Quarterly Dividend of $0.12 Per Share
- Analyst Upgrades Marvell Technology and Viatris, Downgrades Coca-Cola Consolidated and Meta
- Key Deals This Week: Option Care Health, PTC, Energy Transfer
- Pacira BioSciences Shares Rise Over 44% Following Acquisition by Viatris
- Pacira BioSciences Announces $1.65 Billion Acquisition by Viatris
- Viatris Inc - 8-K Filing
- Viatris to Acquire Pacira BioSciences for $1.65 Billion
- Viatris Sues Novo Nordisk Over Generic Version of Wegovy
- Oppenheimer Initiates Coverage of Viatris and Teva with Outperform Ratings
- Viatris Wins Approval for WAKIX in Japan
- Cavendish Reiterates 'Buy' Rating on Shield Therapeutics Following US Product Deal with Viatris
- Merck Announces $0.85 Quarterly Dividend
- Merck Signs Licensing Deals for New Experimental HIV Pill
- Viatris Reports Positive Phase 3 Results in Japan for Nefecon in IgAN
- Viatris Inc - 8-K Filing
- Viatris Inc - 10-Q Filing
- Viatris Reports Q1 2026 Earnings and Financial Performance
- Edwards Lifesciences Appoints Theodora Mistras as New Chief Financial Officer
- QSM Asset Management Acquires 611,000 Shares in Mobileye Global
- QSM Asset Management Invests $5.7 Million in Robert Half Amid Staffing Sector Concerns